Ambev S.A. ABEV3.SA
Ambev S.A. (ABEV3.SA) earns a Piotroski F-score of 8/9 (strong financial health). It pays a dividend yielding 8.10% (safety: at-risk). FY2025 revenue was $88.2B at a 17.6% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Consumer Defensive · percentile among 43 companies
Percentile vs other Consumer Defensive companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 8/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
FAQ
Is ABEV3.SA financially healthy?
Ambev S.A.'s Piotroski F-score is 8/9 (8–9 is excellent, 0–3 weak).
Does ABEV3.SA pay a dividend, and is it safe?
Yes. Ambev S.A. pays a dividend yielding about 8.10% with a 132.0% payout ratio, rated “at-risk” for safety.
How profitable is ABEV3.SA?
In FY2025, Ambev S.A. had a net margin of 17.6% and a return on equity of 17.6%.
Source: company filings via Yahoo Finance · BR · as of 2025-12-31. Figures in BRL; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.